Microbiome and Cancer
Acromancia, a beneficial gut bacteria, shows promise in enhancing the immune system's ability to combat cancer. Research reveals that variations in gut microbiomes can influence the effectiveness of checkpoint inhibitors, with some patients failing to respond due to microbial breakdown of these treatments. Ongoing studies aim to unravel these complex interactions, potentially paving the way for improved cancer therapies.In this clip
From this podcast
Commune with Jeff Krasno
229. Dr. Mahmoud Ghannoum: Your Microbiome & COVID
Related Questions